UPDATE: EU legal action over vaccines "without merit" - AstraZeneca

Mon, 26th Apr 2021 13:54

(Alliance News) - EU legal action taken against AstraZeneca PLC over shortfalls in its delivery of Covid vaccines is "without merit", the drugs giant said Monday.

"We believe any litigation is without merit and we welcome this opportunity to resolve this dispute as soon as possible," the company said in a statement after the European Commission launched proceedings.

Shares in the company were 0.1% higher at 7,572.00 pence each in London on Monday afternoon.

source: AFP

Related Shares

More News

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...